TrialJournal of the American Heart Association2015

Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) Trial.

Xianchen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.